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916Objective: Left ventricular assist devices are used in patients with end-stage dilated cardiomyopathy as a ‘‘bridge
to recovery.’’ However, physiologic and histologic changes under prolonged mechanical unloading have not
been elucidated. Thus, we investigated these changes in the rat heart with dilated cardiomyopathy under mechan-
ical unloading after heterotopic transplantation.
Methods: Six weeks after induction of autoimmunized dilated cardiomyopathy in Lewis rats, 2 types of hearts
were compared (n ¼ 6 each): (1) an unloaded dilated cardiomyopathy heart (DCM-UL) and (2) a dilated cardio-
myopathy heart (DCM). The hearts were evaluated 2 and 4 weeks after transplantation.
Results: Four weeks after transplantation, developed tension of the papillary muscle (indicator of myocardial
contractility) and b-adrenergic response to isoproterenol were better in DCM-UL than in DCM (P ¼ 0.0025
and P<0.0001, respectively). However, half-relaxation time of the papillary muscle (indicator of myocardial re-
laxation) was worse in the DCM-UL group (P<.0001). The ratio of the fibrotic area of the myocardium and the
number of terminal dUTP nick end-labeling–positive myocytes (indicator of myocardial apoptosis) were higher
in DCM-UL than in DCM (P ¼ .0072 and P ¼ .0039, respectively). The mRNA expression of collagen Ia was
also higher in DCM-UL.
Conclusions: Mechanical unloading preserved myocardial contractility and b-adrenergic response but wors-
ened myocardial relaxation. Furthermore, prolonged mechanical unloading has a tendency to increase the ratio
of the fibrotic area and myocardial apoptosis. These unfavorable responses, although secondary to prolonged me-
chanical unloading, may have a negative impact on the bridge to recovery in patients with dilated cardiomyop-
athy. (J Thorac Cardiovasc Surg 2010;140:916-22)Use of a left ventricular assist device (LVAD) has become
an established procedure for patients with end-stage heart
failure. In some cases, the LVAD enables recovery from
a decompensating heart.1 Several investigations have dem-
onstrated a recurrence of heart failure after LVAD explanta-
tion.2 Prolonged unloading also induces depression of
ventricular contractility owing to complicated histologic
and physiologic changes in the myocardium.3 In an experi-
mental study, we demonstrated that mechanical unloading of
the left ventricle (LV) can improve ventricular contractility
and b1- and b2-adrenergic receptor (AR) gene expression.
However, the recovery did not last long in the rat model
with ischemic cardiomyopathy.4-6e Department of Cardiovascular Surgery, Kyoto University Graduate School
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The Journal of Thoracic and Cardiovascular SurgDilated cardiomyopathy (DCM) presents end-stage heart
failure with severe systolic dysfunction and diffuse intersti-
tial fibrosis. However, the physiologic and histologic
changes of DCM under mechanical unloading have not
been well demonstrated. To date, no study has systemati-
cally examined LVADs with DCM as a ‘‘bridge to recov-
ery.’’ Therefore, the present study aimed to investigate the
changes under mechanical unloading in the rat model with
DCM using heterotopic transplantation.MATERIALS AND METHODS
Rat DCM Model
All experimental procedures were conducted according to the guidelines
for animal care stated by Kyoto University and the ‘‘Guide for the Care and
Use of Laboratory Animals,’’ published by the National Institutes of Health.
Five-week-old male Lewis rats (weighing 120–150 g; Japan SLC Inc,
Hamamatsu, Japan) were used. DCM was produced by inducing experimen-
tal myocarditis.7 In brief, 1 mg/0.1 mL of purified cardiac myosin from a por-
cine heart was mixed with an equal volume of Freund’s complete adjuvant
(Difco; BD Diagnostic Systems, Sparks, Md) and injected into a footpad.
Six weeks after immunization, these rats served as a model of heart failure
owing to DCM.
Echocardiography
The rats were anesthetized with ether 6 weeks after autoimmunization.
LV function was evaluated by echocardiography with a 12-MHz phasedery c October 2010
Abbreviations and Acronyms
AR ¼ adrenergic receptor
DCM ¼ dilated cardiomyopathy
DCM-UL ¼ dilated cardiomyopathy (unloaded)
DT ¼ developed tension
LV ¼ left ventricle (ventricular)
LVAD ¼ left ventricular assisted device
LVDd ¼ left ventricular end-diastolic dimension
LVDs ¼ left ventricular end-systolic dimension
mRNA ¼ messenger RNA
TUNEL ¼ terminal dUTP nick end labeling
Muranaka et al Evolving Technology/Basic Sciencearray transducer (HP SONOS 4500; Agilent Technologies, Andover, Mass).
The following parameters were measured by M-mode tracing: LV
end-diastolic dimension (LVDd) and LV end-systolic dimension (LVDs).
Fractional shortening was calculated by the following equation: (LVDd
LVDs)/LVDd 3 100.
Heterotopic Transplantation
The heart and lungs of DCM rats were heterotropically transplanted into
recipient rats to establish mechanical unloading, as described previously.6,8
In brief, the DCM heart and lungs were harvested after ligation of the left
and right superior venae cavae and inferior venae cavae. The ascending
aorta of the donor heart was anastomosed end to side to the abdominal
aorta of the recipient. After heterotopic transplantation, the rats survived
with an operative mortality of less than 5%.
Study Groups
After echocardiographic examination, the rats in which DCM developed
with an LV fractional shortening within 15% to 40%were then divided into
the following 2 groups: (1) the DCM-unloading (DCM-UL) group, which
had the DCM heart and lungs heterotopically transplanted into the recipient
rats (n ¼ 6), and (2) the DCM group, which had the DCM heart without
transplantation (n ¼ 6). The hearts were excised and evaluated at 2 and 4
weeks after transplantation. The hearts of normal Lewis rats served as the
control group (n ¼ 6).E
T
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SPapillary Muscle Tests
Contraction and relaxation. Papillary muscle function was ex-
amined at experiment end points as described previously.5,6,8,9 After the
rats were anesthetized and heparinized, the transplanted hearts in the
DCM-UL group and the DCM or normal hearts in the nontransplanted
group were rapidly removed. Each heart was placed into normal Tyrode so-
lution. Posterior papillary muscle was carefully ligated with a silk thread,
dissected from the LV wall, and mounted in a tissue bath containing
Krebs–Henseleit solution. The bath was maintained at a temperature of
37C and bubbled with oxygen (95%) and carbon dioxide (5%). The pap-
illary muscle was stimulated at 1 Hz with impulses of 5 ms in duration and
5-ms pulses at a voltage approximately 10% above the threshold level. The
papillary muscle was stretched to the length at which maximum tension oc-
curred. After stabilization, isometric tension and half-relaxation time were
recorded digitally at the maximum tension position. Developed tension
(DT) was normalized to the cross-sectional area. DT and half-relaxation
time indicate myocardial contractility and relaxation, respectively.
Responses to isoproterenol. After baseline measurements were
completed, DT was recorded during exposure to the b-adrenergic agonist
isoproterenol. Isoproterenol HCl was dissolved in distilled water and addedThe Journal of Thoracic and Cato the tissue bath to produce a cumulative concentration of 108, 107, and
106 mol/L. DT was measured when the response was maximal (5–10 min-
utes after each addition of isoproterenol).
Histology
The papillary muscle was removed from the heart; the LV myocardium
was transversely sliced into sections (2 mm in diameter) at the base of the
papillary muscle and then fixed in 10% buffered formalin. The remaining
LV myocardium was frozen at80C until analyzed. Transverse sections
of the LV myocardium were stained with hematoxylin–eosin and picrosirius
red reagents. Mean cardiomyocyte diameters were calculated by measuring
20 cells in the LV myocardium under microscope (magnification 3200) as
described previously.5,6,8,9 By means of picrosirius red staining, the
percentage of the fibrotic area was calculated with an IPLab for the
Windows image system (Solution Systems, Inc, Chiba, Japan).
The transverse sections were also used for in situ detection of apoptosis
by the terminal dUTP nick end labeling (TUNEL) assay. TUNEL assay was
performed according to the manufacturer’s protocol (Takara Biomedicals
Inc, Shiga, Japan) as described previously.9 TUNEL-positive cells were
counted in a blinded fashion, with a maximum of 10 randomly chosen fields
in each section.
Analysis of Messenger RNA (mRNA) Expression
Total messenger RNA (mRNA) was prepared from the frozen LV pieces
with TRIzol reagent (Life Technologies Corporation, Carlsbad, Calif), re-
verse transcribed, and amplified with the ABI PRISM 7300 sequence detec-
tor (Applied Biosystems, Inc, Foster City, Calif). Polymerase chain reaction
conditions included 40 cycles of denaturing at 94C for 20 seconds and
primer annealing/extension at 62C for 60 seconds. The polymerase chain
reaction sequence of b1- and b2-AR, collagen Ia, and caspase-3 were re-
ported in our previous research.5,6,8,9 The TaqMan rodent glyceraldehyde-
3-phosphate dehydrogenase control reagent was used to detect rat
glyceraldehyde-3-phosphate dehydrogenase as the internal standard. The
expression level of the target gene was normalized to glyceraldehyde-3-
phosphate dehydrogenase level in each sample.
Statistical Analysis
All data are described as mean  SEM. Differences among groups were
evaluated by the Student t test. Two-way repeated measures analysis of var-
iance was used to assess the inotropic response of the papillary muscle to
isoproterenol. All statistical analyses were performed with Statview for
Windows version 5.0 (SAS Institute, Inc, Cary, NC). Statistical significance
was accepted at the level of P< .05.
RESULTS
Development of DCM
DCM developed in 30 of the 80 rats 6 weeks after autoim-
munization (Table 1). LVDd and LVDs in the DCM group
were larger than those in the control group. LV posterior
wall depth and fractional shortening in the DCM group
were smaller than those in the controls.
LV Weight and Cardiomyocyte Diameter
LV weight in the DCM-UL group after unloading was
lower than in the DCM group at 2 and 4 weeks
(P< .0001, respectively), as shown in Table 2. LV myocar-
dial diameter in the DCM-UL group after unloading was
also smaller than that in the DCM at 2 and 4 weeks
(P ¼ .0001, P< .0001, respectively), as shown in Table 2.
These results indicated that mechanical unloading afterrdiovascular Surgery c Volume 140, Number 4 917
TABLE 1. Baseline echocardiographic data
Control group
(n ¼ 6)
DCM group
(n ¼ 24)
LVDd (mm) 7.3  0.2 8.4  0.2*
LVDs (mm) 3.2  0.2 6.1  0.2*
PWd (mm) 1.5  0.2 1.1  0.0*
FS (%) 56.8 1.8 27.7  1.4*
LVDd, Left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic
dimension; PWd, posterior wall depth; FS, fractional shortening; DCM, dilated cardio-
myopathy. Data are presented as mean  SEM. *Compared with the control group
(P< .05).
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that the atrophy progressed with time.
Papillary Muscle Tests
DT and half-relaxation time are shown in Figure 1, A and
B, respectively. The DT of papillary muscle after transplan-
tation was higher in the DCM-UL group than in the DCM
group at 2 and 4 weeks (P¼ .0016, P¼ .0025, respectively).
Half-relaxation time of the papillary muscle was higher in
the DCM-UL group than in the DCM group at 2 and 4 weeks
(P ¼ .017, P< .0001, respectively).
b-adrenergic response of the papillary muscle is presented
in Figure 1, C. Inotropic responses to isoproterenol (108,
107, and 106 mol/L) after unloading were higher in the
DCM-UL group than in the DCM group at 2 and 4 weeks
(P< .0001).
Histology
Myocardial fibrotic area. Myocardial fibrotic area stained
with picrosirius red is shown in Figure 2. There was no dif-
ference in the ratio of the fibrotic area between the DCM-UL
group and the DCM group at 2 weeks after unloading. How-
ever, the ratio of the fibrotic area in the DCM-UL group was
larger than in the DCM group 4 weeks after unloading
(P ¼ .0072).
TUNEL-positive cardiomyocyte. The TUNEL-positive
myocyte count (indicator of cardiac apoptosis) is shown in
Figure 2. There was no difference in TUNEL-positive myo-
cytes between the DCM-UL and DCM groups (P ¼ .099) 2
weeks after unloading. However, 4 weeks after unloading,
the number of TUNEL-positive myocytes in the DCM-ULTABLE 2. Morphologic and histologic studies
T
Control DCM
LV weight (g) 0.71  0.29 0.96  0.51*
Myocytes diameter (mm) 21.3  1.2 30.0  1.3*
Fibrotic area (%) 0.5  0.1 16.2  2.5*
TUNEL-positive
cardiomyocyte (/104)
0.35  0.14 3.43  0.52*
LV, Left ventricle; TUNEL, terminal dUTP nick end-labeling; DCM, dilated cardiomyopathy
DCM at the same time point.
918 The Journal of Thoracic and Cardiovascular Surggroup was higher than that in the DCM group
(P¼ .0039). These results indicated that myocardial apopto-
sis progressed with time under mechanical unloading in the
rat DCM heart.
Analysis of mRNA Expression
The mRNA expression of b1-ARs, b2-ARs, and collagen
Ia was higher in the DCM-UL group than in the DCM group
2 weeks after transplantation (Table 3). There was no differ-
ence in caspase-3 mRNA expression between the 2 groups.
DISCUSSION
Main Findings
To our knowledge, this is the first study to investigate the
physiologic and histologic changes in mechanical unloading
of the rat DCM heart. The present study demonstrated the
following novel findings in the rat DCM model with hetero-
topic transplantation: mechanical unloading preserved
myocardial contractility and response to b-adrenergic stim-
ulation; however, unloading impaired myocardial relaxa-
tion. Mechanical unloading also increased myocardial
atrophy and the ratio of the fibrotic area and apoptosis
with time. Evaluation with mRNA expression was consis-
tent with these results. Thus, prolonged mechanical unload-
ing may preserve myocardial contractility and response to
b-adrenergic stimulation, but it impairs myocardial relaxa-
tion and facilitates myocardial stiffness and apoptosis.Unloading and Myocardial Contractility
Many investigations have revealed that mechanical
unloading with LVAD induces the myocardial recovery of
systolic functions in patients with end-stage heart fail-
ure.1,10,11 LVAD support shifts leftward the slope of the
pressure–volume loop and increases maximum energy
owing to volume and pressure unload of the LV.12 In clinical
and animal studies using isolated myocardium, trabeculae,
and papillary muscle, mechanical unloading with LVAD
support and heterotopic transplantation has improved
fractional shortening, time to peak contraction, and the
force–frequency relationship.10,12,13 LVAD support has
also normalized b-adrenergic response and b-AR density.
Furthermore, it has also upregulated gene expression forwo weeks Four weeks
DCM-UL DCM DCM-UL
0.57  0.12y 0.96  0.33* 0.47  0.37*,y
19.9  1.0y 32.0  0.6* 16.6  0.5*,y
19.3  3.5* 12.0  1.9* 22.3  2.4*,y
4.77  0.52* 2.13  0.23* 3.35  0.23*,y
; DCM-UL, dilated cardiomyopathy (unloaded) *P<.05 vs control group. yP<.05 vs
ery c October 2010
FIGURE 1. Analysis of changes in DT, half-relaxation time, and inotropic response to isoproterenol with isolated papillary muscle at 2 and 4 weeks after trans-
plantation. All values are represented as mean SEM. DT, Developed tension; DCM, dilated cardiomyopathy; DCM-UL, dilated cardiomyopathy (unloaded).
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triphosphatase subtype 2a, the ryanodine receptor, and the
sarcolemmel Naþ-Ca2þ exchanger.14
Despite the recovery of systolic function, prolonged me-
chanical unloading with LVAD support has not always
yielded positive results. Xydas and associates3 reported
that cardiac recovery peaked at 60 days.
In the present study, mechanical unloading preserved the
DT of the papillary muscle and the inotropic response tob-ad-
renergic stimulation in rats with DCM for 4 weeks after trans-
plantation. These results are consistent with our previous
reports in the rat model with ischemic cardiomyopaathy.4,8
Preservation of myocardial contractility may relate to some
other mechanisms. In our study, an analysis of the b1- and
b2-AR mRNA expression demonstrated that mechanical
unloading upregulated the b-AR gene expression, and it
was compatible with the papillary muscle test.
These findings suggest that mechanical unloading can
have a substantial impact on hemodynamics and cardiac
contractility by upregulation of b-ARs. This mechanism is
one of the most important factors in the case for a bridge
to recovery for patients with end-stage heart failure. Thus,
further studies are needed to clarify how long the contractile
recovery could last after mechanical unloading.
Unloading and Myocardial Relaxation
Early investigation has revealed that LVAD support shifts
the end-diastolic pressure–volume relationship slope left-The Journal of Thoracic and Caward and increases myocardial stiffness.12 In a similar re-
port, Brinks and associates15 described an animal model
with 30 days of mechanical unloading.
We evaluated the half-relaxation time of the isolated
papillary muscle as an indicator of myocardial relaxation.
Welsh and colleagues13 reported that the half-relaxation
time of an isolated cardiomyocyte was unchanged after 2
weeks of mechanical unloading of the nonfailing heart in
the rat model. On the other hand, Soppa and coworkers16
demonstrated the prolongation of half-relaxation time af-
ter 5 weeks of mechanical unloading in the normal rat
heart.
In the present study, half-relaxation time in the DCM-UL
group was prolonged compared with that of the DCM group
2 and 4 weeks after transplantation. Histologic assessment
revealed that the ratio of the fibrotic area of the myocardium
was more prominent in the DCM-UL group than in the DCM
group from the early phase onward.
Myocardial Fibrotic Area
Whether myocardial fibrosis progresses under mechanical
unloading has been a source of controversy. Bruckner and
coworkers17 reported that prolonged mechanical unloading
reduces myocardial fibrosis. On the other hand, many re-
ports have shown that mechanical unloading increases inter-
stitial fibrosis.4-6,18 Klotz and associates19 demonstrated an
increase in LV cross-linked collagen content and tissue an-
giotensin I and II levels after LVAD support in DCM. Inrdiovascular Surgery c Volume 140, Number 4 919
FIGURE 2. A, Hematoxylin–eosin stained sections of the LV myocardium at 2 and 4 weeks after transplantation. B, Picrosirius red–stained sections of the
LV myocardium. C, TUNEL-stained sections of the LV myocardium. Arrow indicates TUNEL-positive cardiomyocyte (bar ¼ 100 mm). LV, Left ventricle;
TUNEL, terminal dUTP nick end labeling; DCM, dilated cardiomyopathy; DCM-UL, dilated cardiomyopathy (unloaded).
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Bruggink and colleagues20 reported that extracellular matrix
volume increased during the first 200 days after LVAD im-
plantation; after 200 days, extracellular matrix volume
decreased with time.
In the present study, picrosirius red staining highlighted
the ratio of the fibrotic area in unloading hearts. We believe
that this finding is a result of certain histologic mechanisms.
Fibrotic tissue does not reduce in parallel with cardiomyo-
cyte volume. Therefore, an uneven change in myocardial
content may contribute to heighten the ratio of the fibrotic
area after unloading. Similar findings have been presented
in prior studies.19,21 We believe that an increase in the ratio
of fibrotic tissue plays an important role in the stiffness of
isolated papillary muscle. Moreover, this may exert
a negative influence on LV systolic and diastolic function.Myocardial Apoptosis
Schena and coworkers22 demonstrated an increase in
caspase-3 activity after mechanical unloading in the ratTABLE 3. Messenger RNA expressions
Control DCM
b1-AR/GAPDH 3.44  0.38 4.15  0.27
b2-AR/GAPDH 2.50  0.21 3.40  0.19
Collagen Ia/GAPDH 1.36  0.41 9.36  1.46
Caspase-3/GAPDH 0.12  0.14 7.45  0.73
AR, Adrenergic receptor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; DCM, dila
920 The Journal of Thoracic and Cardiovascular Surgmodel with a normal heart. We9 previously reported that me-
chanical unloading increased TUNEL-positive myocytes
and upregulated mRNA expression of caspase-3 in the rat is-
chemic cardiomyopathy model. In the present study,
caspase-3 gene expression was higher in the DCM-UL
group than in the DCM group, and the TUNEL-positive my-
ocyte cell count was higher than that in the DCM group at 4
weeks. These results indicate that mechanical unloading
may induce myocardial apoptosis. On the other hand, sev-
eral studies have demonstrated an antiapoptotic effect after
LVAD implantation.23,24 This discordance may be because
of different procedures of mechanical unloading between
heterotopic heart transplantation in the animal model and
LVAD in a clinical situation.Limitations
The current study has some limitations. First, the DCM
model in this study was induced by experimental myocar-
ditis, which accompanied LV dilation, systolic dysfunction,
and collagen deposition. This animal model may not reflectDCM-UL
P value for DCM vs DCM-
UL
6.99  0.75 .0051
4.76  0.28 .0025
14.09  1.11 .0275
9.82  1.04 .0987
ted cardiomyopathy; DCM-UL, dilated cardiomyopathy (unloaded).
ery c October 2010
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lished and used as a DCM model in other reports.7 There-
fore, we consider that this model simulates the DCM
model. Second, heterotopic transplantation in this study
may not replicate the unloading seen in cases in which
an LVAD is inserted in a DCM heart. However, we con-
sider this procedure to be a close simulation of LVAD
compared with conventional heterotopic transplantation
procedures reported previously, given that the LV of trans-
planted heart is perfused and loaded with a small amount of
blood.8 However, the possibility remains that the unventi-
lated lungs influence this transplantation model. Third, al-
though heterotopic transplantation involves only a short
ischemic time, we consider that the transplantation proce-
dure used in this study can halve ischemic time because
of the single anastomosis required compared with that of
conventional transplantation.8 Moreover, we used cold car-
dioplegic solution and ice protection during transplantation
to minimize the negative effects resulting from ischemia.
Fourth, the isolated papillary muscle function test used in
this study may not reflect the global function of the LV.
However, this procedure is established and represented
elsewhere.5,8,9 Therefore, we consider this procedure to
be one of the functional indicators of the LV. Fifth, in
this study, we evaluated mRNA gene expression as
a molecular assessment. Therefore, it may not reflect the
expression of proteins precisely. However, we believe
that the result may help indicate the basic molecular
changes. Finally, there is a possibility that the
denervation induced by transplantation may have altered
the response of b-ARs. A previous investigation reported
that functional and b-adrenergic density recoveries were
independent of cardiac denervation and that other
humoral molecules present in the patient with heart
failure might influence ventricular remodeling.25 Thus, in
our opinion there is a possibility that humoral stimulation
is one of the factors that contribute to improved b-AR
mRNA expression.
CONCLUSIONS
Mechanical unloading preserved myocardial contractility
and b-adrenergic response in the DCM rat heart. However,
myocardial relaxation was impaired. Furthermore, myocar-
dial atrophy, the ratio of the fibrotic area, and apoptosis all
increased with time. These unfavorable responses, although
secondary to mechanical unloading, may have a negative
impact on a bridge to recovery in DCM patients. Further in-
tervention is needed to preserve cardiac function and prevent
myocardial stiffness and apoptosis.
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